|
MechanismNMDA receptor antagonists |
Active Org.- |
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date19 May 2015 |
100 Clinical Results associated with Millenia Hope Pharmaceuticals, Inc.
0 Patents (Medical) associated with Millenia Hope Pharmaceuticals, Inc.
100 Deals associated with Millenia Hope Pharmaceuticals, Inc.
100 Translational Medicine associated with Millenia Hope Pharmaceuticals, Inc.